Valuation: MiniMed Group, Inc.

Market Cap 6.33B 5.49B 5.18B 4.7B 8.81B 607B 8.87B 61.82B 23.82B 308B 23.78B 23.25B 979B P/E 2027 *
37.4x
P/E 2028 * 30x
Enterprise Value 6.03B 5.23B 4.93B 4.48B 8.4B 578B 8.46B 58.92B 22.7B 293B 22.66B 22.16B 933B EV / Sales 2027 *
1.76x
EV / Sales 2028 * 1.54x
Free-Float
10.08%
Yield 2027 *
-
Yield 2028 * -
1 day-3.44%
1 week-6.97%
Current month+7.08%
1 month+7.67%
3 months+44.63%
6 months+35.93%
1 week 21.27
Extreme 21.27
23.74
1 month 18.85
Extreme 18.85
24.43
Current year 10.65
Extreme 10.65
24.43
1 year 10.65
Extreme 10.65
24.43
3 years 10.65
Extreme 10.65
24.43
5 years 10.65
Extreme 10.65
24.43
10 years 10.65
Extreme 10.65
24.43
Date Insider Type Main position Quantity % Market Cap. Importance
7/31/26 Tax

Chief Executive Officer

-31,350 0.0112%
7/31/26 Tax

Chief Technology Officer

-8,012 0.0029%
7/31/26 Tax

General Counsel

-1,762 0.0006%
Change 5-day change 1-year change 3-year change Capi.($)
-3.44%-6.97% - - 6.33B
+0.66%+0.14%+21.50%+18.64% 12.52B
+1.54%-2.30%+12.32%+16.84% 6.59B
+1.91%-7.67%+20.86%+6.59% 5.51B
+2.24%-1.24%-17.26%+41.62% 5.04B
+0.59%-1.12%-34.72%-24.13% 3.76B
+2.35%-5.64%+25.00%-18.96% 1.81B
0.00%+6.83%-1.29%+164.64% 1.78B
+1.46%-4.10%+45.98%-18.23% 1.57B
-1.99%-5.85%-23.52%+35.07% 1.33B
Average +0.54%-3.17%+5.43%+24.68% 4.62B
Weighted average by Cap. +0.57%-2.67%+8.30%+19.47%

Financials

2027 *2028 *
Net sales 3.44B 2.98B 2.81B 2.55B 4.78B 329B 4.82B 33.57B 12.93B 167B 12.91B 12.62B 531B 3.72B 3.22B 3.04B 2.76B 5.18B 357B 5.21B 36.33B 14B 181B 13.97B 13.66B 575B
Net income 181M 157M 148M 134M 252M 17.33B 253M 1.77B 680M 8.79B 679M 664M 27.95B 239M 207M 195M 177M 333M 22.91B 335M 2.33B 899M 11.62B 898M 878M 36.94B
Net Debt -297M -257M -243M -220M -413M -28.47B -416M -2.9B -1.12B -14.44B -1.12B -1.09B -45.92B -600M -520M -491M -445M -835M -57.53B -841M -5.86B -2.26B -29.18B -2.25B -2.2B -92.78B
Logo MiniMed Group, Inc.
MiniMed Group, Inc. is a medical technology company, which develops, manufactures, and markets a comprehensive suite of solutions for the management of diabetes. Its fully integrated system addresses pain points for people with diabetes (PWD): health outcomes and complexity of diabetes management. The MiniMed 780G is its flagship AID system. The MiniMed 780G system uses its SmartGuard dosing algorithm technology, which automatically delivers basal insulin and auto-correction doses every five minutes based on sensor glucose readings. The MiniMed 780G consists of the MiniMed 780G insulin pump, the Simplera Sync CGM sensor, and the instinct sensor. Its platform of clinically effective solutions for PWD requiring insulin therapy includes Automated Insulin Delivery (AID) Systems and a Smart Multiple Daily Injection (MDI) System. Its pipeline products are the MiniMed Flex, screenless insulin pump, next-generation Vivera dosing algorithm, and MiniMed Fit patch pump with extended wear.
Employees
-
Date Price Change Volume
26-09-14 US$21.70 -3.58% 2,537,990
26-09-11 US$22.50 +0.27% 1,423,592
26-09-10 US$22.44 -1.41% 1,652,540
26-09-09 US$22.76 -2.40% 1,587,725
26-09-08 US$23.32 +0.15% 1,052,149
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
13
Last Close Price
22.50USD
Average target price
24.83USD
Spread / Average Target
+10.37%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. MMED Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!